Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 17, Number 10—October 2011

Dispatch

Bacteremia and Antimicrobial Drug Resistance over Time, Ghana

Uwe GroßComments to Author , Sylvarius K. Amuzu, Ring de Ciman, Iparkhan Kassimova, Lisa Groß, Wolfgang Rabsch, Ulrike Rosenberg, Marco Schulze, August Stich, and Ortrud Zimmermann
Author affiliations: University Medical Center, Göttingen, Germany (U. Groß, L. Groß, O. Zimmermann); Holy Family Hospital, Nkawkaw, Ghana (S.K. Amuzu); St. Francis Xavier Hospital, Assin Foso, Ghana (R. de Ciman); St. Martin de Porres Hospital, Eikwe, Ghana (I. Kassimova); Robert Koch Institute, Wernigerode, Germany (W. Rabsch); Helios Hospital, Northeim, Germany (U. Rosenberg); Medical Mission Institute, Würzburg, Germany (M. Schulze, A. Stich)

Main Article

Table 2

Ratio in percentages of antimicrobial drug–resistant bacterial isolates obtained from patients with bacterial bloodstream infections, Ghana, 2001–2002 and 2009*

Bacteria type and years
PEN
OXA
AMP
CEF
GEN
SMX
CMP
CIP
Salmonella enterica serovar Typhi
2001–2002 93.3 1.7 0 86.7 88.3 0
2009


100
0
0
100
100
0
Nontyphoid Salmonella spp.
2001–2002 100 20.0 12.5 90.0 82.5 0
2009


100
0
0
88.9
77.8
0
Enterobacteriaceae other than Salmonella spp.
2001–2002 100 50.0 60.0 80.0 80.0 0
2009


100
87.5
37.5
62.5
50.0
50.0
Nonfermenters
2001–2002 91.7 75.0 16.7 41.7 100 0
2009


100
100
15.4
53.8
92.3
0
Staphylococcus aureus
2001–2002 81.3 0 81.3 0 0 68.8
2009
100
0
100

0
0


All bacteria
2001–2002 93.6 18.9 10.7 72.1 84.3 0
2009 100 41.7 10.4 72.9 84.4 8.9

*Blank cells indicate no testing performed. PEN, penicillin; OXA, oxacillin; AMP, ampicillin; CEF, cefuroxime; GEN, gentamicin; SMX, trimethoprim/sulfamethoxazole; CMP, chloramphenicol; CIP, ciprofloxacin.

Main Article

TOP